valsartan has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelkawy, M; El-Hanboushy, S; Fayez, YM; Lotfy, HM; Marzouk, HM | 1 |
| Ahmad, A; Alama, MN; Alharthi, TS; Alkreathy, HM; Alluhabi, SI; Alqarni, F; Alrafiah, AR; Damanhouri, ZA | 1 |
2 other study(ies) available for valsartan and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Eco-friendly spectrophotometric evaluation of triple-combination therapies in the treatment strategy of patients suffering from hypertension during coronavirus pandemic - Spectralprint recognition study.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Coronavirus; Humans; Hydrochlorothiazide; Hypertension; Leukemia, Myeloid, Acute; Pandemics; Spectrophotometry; Valsartan | 2022 |
Efficacy and safety of single pill combination of amlodipine and valsartan in hypertensive Saudi patients.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Leukemia, Myeloid, Acute; Prospective Studies; Saudi Arabia; Tetrazoles; Valsartan | 2023 |